US6818422B2ExpiredUtilityPatentIndex 49
Substances K97-0239 and process for producing the same
Est. expiryApr 3, 2021(expired)· nominal 20-yr term from priority
C07K 5/0202C07K 7/54A61K 38/00C07K 5/0205
49
PatentIndex Score
0
Cited by
4
References
6
Claims
Abstract
A microorganism capable of producing substances K97-0239 comprising K97-0239A represented by the following formula [I]: and K97-0239B represented by the following formula [II]: is cultured in a medium and the substances K97-0239 thus accumulated in the medium are collected from the culture medium. The obtained substances have a low toxicity and specifically inhibit the foaming of macrophages. Owing to these characteristics, they are useful in preventing and treating human arteriosclerosis and diseases caused thereby.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A K97-0239 substance comprising K97-0239A substance represented by formula [I]:
and K97-0239B substance represented by formula [II]:
2. A process for production of K97-0239 substance comprising culturing a microorganism belonging to genus Streptomyces and having ability to produce K97-0239 substance, accumulating K97-0239 substance in a cultured mass and isolating K97-0239 substance from said cultured mass.
3. The process according to claim 2 wherein a microorganism belonging to genus Streptomyces and having ability to produce K97-0239 substance is Streptomyces sp. K97-0239 FERM BP-7514.
4. A microorganism belonging to genus Streptomyces and having ability to produce K97-0239 substance, and wherein said microorganism is Streptomyces sp. K97-0239 FERM BP 7514 and mutant strains thereof.
5. A K97-0239 substance comprising K97-0239A substance represented by formula [I]:
6. A K97-0239 substance comprising K97-0239A substance represented by formula [II]:Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.